Paper 49 — Signal
Sometimes lack is both signal and trigger for processes that automate. The body knows how to heal, but is it getting the message?

Abstract

Every cell in the body retains a blueprint for repair unless it's damaged or silenced by a mechanism that actively maintains the suppression. Healing and regeneration is the body's job, and it does it willingly and automatically when given the resources. Sometimes the trigger is absence itself — the shortage of something the body relies on, which stands the suppressor down and drives the body to break down and recycle what it already has.

1. Locked In

The body is automatically regenerating by its very nature unless something tells it not to. That something might be the automation itself.

The mechanism is DNA methylation, where a methyl group of one carbon and three hydrogens attaches to cytosine bases in the promoter region of a gene. When methyl groups accumulate on a gene's promoter, the transcription machinery cannot access it, leaving the gene present, intact, and fully functional but covered so that nothing can read it.

The enzyme that applies this methylation is DNMT3a, DNA methyltransferase 3a. It is a de novo methyltransferase, meaning it establishes new methylation patterns rather than simply maintaining existing ones. During development, DNMT3a progressively methylates regeneration-associated genes including ASCL1, Oct4, Lin28, and Nestin, silencing them as the organism matures. This is why young mice can regenerate retinal neurons and adults cannot, because the genes didn't disappear but the enzyme covered them.

The critical evidence comes from the eye. Müller glia, the support cells in the retina, contain the ASCL1 gene that enables complete retinal regeneration in zebrafish and birds. Fish and birds shrug off retinal injury because their Müller glia revert to neural stem cells, travel back in developmental time, and produce new retinal neurons until vision returns. The same gene exists in human Müller glia but remains epigenetically locked.

A 2016 study (Reyes-Aguirre & Lamas) showed how close the mammalian eye comes to regenerating before the mechanism shuts it down. After retinal injury in mice, Oct4, a key regeneration gene, activates within 4 hours and methylation at its promoter drops. By 24 hours DNMT3b, a second de novo methyltransferase in the same family, re-methylates it and the gene goes silent again. The eye tried to regenerate, briefly unlocked the genes, began the process, and was re-silenced before it could complete.

The obstruction is not permanent but actively maintained, because DNMT3a continuously re-applies the methylation, and if the enzyme stops, the methyl groups degrade and the gene becomes readable again. The suppression of regeneration is a process, not a state, which means regeneration is always possible but not always available to the mechanisms that would unlock it.

2. Triggered

Some companies are editing genes directly. In 2025, researchers demonstrated that transiently inhibiting DNMT3a using CRISPR for just 3-5 days caused mouse Müller glia to reactivate ASCL1, Lin28, and Nestin, and the cells began dedifferentiating, migrating, and proliferating in all the hallmarks of regeneration. Nothing was added or replaced; the enzyme that maintains the suppression was temporarily removed, and that alone triggered the genes underneath to reactivate on their own.

CRISPR proved the principle, but CRISPR is an engineered gene-editing tool. The body already has natural pathways that achieve the same result: temporarily suppressing the enzyme that suppresses regeneration.

Fasting is a natural way the body can arrive at a similar result. When nutrient signaling drops, autophagy activates and directly suppresses DNMT3a expression. A study on cancer cells confirmed the mechanism, showing that starvation-activated autophagy remodels the DNA methylation profile by inhibiting DNMT3a expression. The same pathway Paper 47 documented, where mTOR downregulates, AMPK activates, and the cell enters maintenance mode, simultaneously removes the molecular lock on regeneration genes, meaning fasting doesn't just clear damaged organelles but unlocks the genes that were waiting for a signal to reach them.

Dietary compounds are a second route. A 2025 systematic review confirmed that food-derived bioactive compounds act as natural DNMT inhibitors:

EGCG, the primary polyphenol in green tea, inhibits DNMT1, the maintenance methyltransferase that preserves methylation patterns during cell division. Theaflavins from black tea and chlorogenic acid from coffee directly inhibit DNMT3a at physiologically relevant concentrations. Apigenin found in parsley, chamomile, and celery, chrysin found in honey and passionflower, and luteolin found in peppers, celery, and thyme inhibit both DNA methyltransferases and histone methyltransferases simultaneously. These are dual-action compounds that open the lock at two levels.

Vitamins A and C are a third. The enzyme that actively removes methyl groups is Tet3 (Ten-Eleven Translocation 3), and it is regulated by metabolic factors including iron, vitamin A, and vitamin C, which means these vitamins don't just support general health but support the specific enzyme responsible for removing the molecular obstruction from regeneration genes. A 2025 study confirmed that NMDA-induced retinal injury increases Tet3 expression, which in turn upregulates ASCL1, Lin28, and Nestin. When Tet3 was knocked down, the injury-induced upregulation of regeneration genes was impaired, and when Tet3 was overexpressed, cells began showing neuronal markers without any injury stimulus at all.

The lock is maintained by an enzyme. The enzyme is suppressed by autophagy. Autophagy is activated by withdrawal.

3. The Address

Fasting suppresses DNMT3a across the body, but regeneration does not follow everywhere it acts. In Müller glia, Oct4 reactivated only after retinal injury, not in undamaged retina, with methylation dropping at 4 hours post-injury specifically in the damaged tissue. The targeting comes from the damage itself.

Two conditions operate simultaneously. The global condition, which includes fasting, autophagy, and dietary compounds, lowers the overall methylation pressure across the body. DNMT3a slows down everywhere. The second condition is local. Damaged tissue produces its own signals including inflammation, damage-associated molecular patterns (DAMPs), hypoxia at the injury site, and altered ion concentrations. These local signals direct Tet3 and other demethylases to actively remove methyl groups at the specific location where regeneration is needed.

The global condition lowers the threshold. The local damage provides the address.

This may be why a constantly-fed body with an old injury never fully heals: the de novo methyltransferases run at full capacity, re-methylating the genes within about 24 hours, overwhelming the local damage signal before repair can proceed. In a fasting body, with DNMT3a suppressed and methylation pressure reduced, the same damage signal has longer to act before the genes are re-methylated. The window that would otherwise close in a day stays open longer.

The body already knows where it's hurt and has been signaling from those sites the entire time, but what fasting does is stop drowning out those signals with a globally locked epigenome. This is Paper 36's principle: lower the noise floor and the signal that was always there becomes audible.

4. The Timeline

The fasting signal is not a single event but a cascade of thresholds, each activating a different process at a different depth.

0-12 hours: blood glucose stabilizes, insulin drops, the body begins depleting glycogen stores. The metabolic shift begins.

12-18 hours: glycogen depletes, the body transitions to fat burning. Autophagy begins increasing above baseline, sending the first signal to DNMT3a. Ketone production begins.

18-24 hours: autophagy ramps significantly as growth hormone surges and growth-signaling pathways including mTOR and IGF-1 begin to quiet, flipping the cellular maintenance switch from growth mode to repair mode.

24-48 hours: autophagy reaches significant elevation, approximately 300% above baseline. Stem cells begin participating in tissue regeneration. DNMT3a suppression deepens as autophagy intensifies. The methylation pressure across the genome continues dropping.

48-72 hours: autophagy peaks and stem cell activity increases substantially as the immune system begins a renewal process where old immune cells are broken down and new ones generated from hematopoietic stem cells, with deep cellular repair and conservation processes fully active.

The 16-hour intermittent fast touches the first threshold. The 72-hour fast reaches the deepest. The timeline is not fixed. Metabolic health, activity level, prior diet, and whether the body is keto-adapted all influence when each threshold is crossed. But the sequence is consistent: depletion, then transition, then maintenance, then regeneration.

What Paper 47 described as "the signal of lack" is not a single event but this graduated sequence.

Underneath the thresholds is an alternation, and naming it is the point of this section. Each step is either a trigger or a building block, a signal that calls for the shift or a material the shift makes available, and the cascade proceeds by turning one into the next.

The trigger is withdrawal itself. Food stops, blood glucose falls, and insulin falls with it, and the drop in insulin, along with the rise in glucagon that answers it, is the signal every later step reads. From that single reversal the building blocks are released in order. First the liver breaks stored glycogen back into glucose, spending the body's most immediate reserve to hold blood sugar steady through roughly the first day. As that reserve empties, two deeper supplies open: the liver assembles new glucose from glycerol, lactate, and amino acids, and fat cells release free fatty acids, the body beginning, as it is usually put, to burn its own fat. Those fatty acids travel to the liver and are converted into ketone bodies, and the brain, which cannot burn fat directly, shifts to running on them. The reserve becomes the fuel.

And the fuel becomes the signal, because the same molecules that feed the body in withdrawal also instruct it. As cellular energy falls, AMPK activates and mTOR quiets, the master switch from growth into maintenance, and that switch releases autophagy, the recycling machinery that is itself a source of building blocks, breaking damaged proteins and organelles back down into the amino acids and lipids from which new structure is built. Autophagy is where the two halves of this paper meet: it supplies materials and, as Section 2 described, suppresses DNMT3a, lowering the lock on regeneration genes at the same moment the raw materials for regeneration are being liberated. The ketone beta-hydroxybutyrate does the same double duty, serving as fuel while also acting as an epigenetic signal that loosens chromatin. The trigger calls, the building blocks answer, and some of the building blocks turn out to be triggers in their own right.

One honesty note belongs here, because the sequence is better established than its timing. The hormonal and fuel steps, insulin and glucagon, glycogen depletion, gluconeogenesis, lipolysis, ketogenesis, and the fall in mTOR, are measured directly in fasting humans. The magnitude and exact timing of autophagy are not. The clearest human study, a seventy-two-hour fast, found mTOR signaling roughly halved and the autophagy marker LC3B-II raised by about a third, but a marker that should fall if recycling were proceeding cleanly instead rose slightly, leaving the true rate ambiguous. The dramatic figures often attached to specific hours come largely from animals and cultured cells. The order of the cascade is firm; the clock on its deepest step is not.

5. The Channel That Light Opens

The eye is the organ that severed itself from the body's vascular routing network, leaving it avascular, immune-privileged, and without blood vessels to carry signals. By Paper 48's framework the eye should be unreachable, disconnected from the organ crosstalk axes and unable to receive the cross-organ regeneration signals that travel through blood. But light does not need blood vessels.

Red light at 630-670nm penetrates skin and tissue to reach mitochondria directly. The photons are absorbed by cytochrome c oxidase, a key enzyme in the mitochondrial electron transport chain, increasing ATP synthesis and triggering downstream effects on inflammation, tissue repair, and cellular function. 630nm concentrates energy in upper tissue layers; 660nm reaches the mid-to-deep dermis; 810nm penetrates through scalp and skull to reach brain tissue.

For the eye specifically, the evidence is direct. 670nm light upregulates cytochrome c oxidase expression and reduces inflammation in a mouse model of age-related macular degeneration. The treatment reduced complement C3 (an inflammatory marker), downregulated stress markers in Müller glia, and modified macrophage morphology in the outer retina. This was delivered not as focused laser treatment but as supplemented environmental light, 6 minutes twice daily for 14 days.

670nm light has been shown to reduce reactive oxygen species production and preserve mitochondrial integrity in Müller glia under diabetic retinopathy conditions. It modulates inflammatory mediators and reduces oxidative stress through a channel the eye never blocked, because while the eye excluded blood vessels to preserve optical clarity, it did not exclude light, and light is the signal the eye was built to receive.

The retina contains Müller glia with locked ASCL1 genes. Fasting suppresses the enzyme maintaining the lock. Dietary compounds and vitamins support the enzyme that removes it. And light at 670nm reaches the Müller glia directly, boosting mitochondrial function, reducing inflammation, and creating the local conditions under which demethylation may proceed. Each pathway reaches the same target through a different channel.

6. Scar Tissue

Scar tissue is the objection. If the body knows where it's damaged and has the enzymes to repair, why do some injuries never heal? Why do keloids persist?

Keloid and scar tissue persist because of a specific molecular imbalance. The body has matrix metalloproteinases (MMPs), enzymes whose job is to degrade and remodel collagen in the extracellular matrix. MMP-1, MMP-2, MMP-9, MMP-13 are collagenases. They exist to break down excess or disordered collagen. But in keloids, tissue inhibitors of metalloproteinases (TIMPs) are overexpressed, with TIMP-1 and TIMP-2 at significantly higher levels than in normal scar tissue. The degraders are present but the inhibitors are drowning them out.

The keloid follows the same structural pattern at the tissue level, where a lock is maintained by an active suppressor: TIMPs suppress MMPs the way DNMT3a suppresses regeneration genes, so the scar persists not because the body lacks the tools to remodel it but because the inhibitor of those tools is overexpressed.

And the keloid's physical structure mirrors the disconnection Paper 48 documents, because collagen nodules in keloids are avascular and unidirectional with no blood supply and no connection to the body's routing network, making them the tissue equivalent of the cancer cell that closed its gap junctions, disconnected from the system, growing on their own terms, and unreachable by the signals that would remodel them.

What breaks scar tissue down follows the same principle: suppress the suppressor and reconnect the channel. Pressure decreases tissue metabolism and increases collagen breakdown, a mechanical signal that shifts the MMP/TIMP balance. Massage physically moves the tissue, restoring circulation to avascular scar, reconnecting it to the routing network. Silicone therapy works through wound hydration, restoring a moisture gradient and another potential differential.

And autophagy upregulates MMP activity, so the same fasting-autophagy pathway that suppresses DNMT3a also shifts the MMP/TIMP balance toward degradation of disordered extracellular matrix. The body's sorting intelligence, its ability to distinguish what functions from what doesn't, operates on scar tissue the same way it operates on damaged mitochondria by tagging it, breaking it down, and recycling the materials.

The pattern is the same at every level: a capacity that isn't lost but suppressed by an active mechanism, in a body that already knows where the damage is and waits for the conditions under which repair can reach it.

7. The Medium

Every signal this paper describes travels through blood. The DNMT inhibitors from food reach cells through plasma. The erythropoietin that triggers bone marrow regeneration travels through plasma. The growth factors, the cytokines, the hormones that coordinate the organ crosstalk axes documented in Paper 48 all move through the same medium, and if that medium is compromised, the signals degrade before they arrive.

Blood plasma constitutes roughly 55-60% of blood volume and carries water, salts, sugars, fats, hormones, and proteins to every tissue in the body. It is the delivery system for every dietary compound that suppresses DNMT3a, every vitamin that supports Tet3, and every signaling molecule that coordinates cross-organ repair. Red blood cells make up most of the remaining volume and carry oxygen bound to hemoglobin, an iron-rich protein that loads oxygen in the lungs and releases it in tissue. The oxygen differential between healthy tissue and damaged tissue is the local signal that directs Tet3 to remove methyl groups at the specific site where regeneration is needed, which means the precision of the addressing mechanism from Section 3 depends in part on red blood cells delivering oxygen with enough specificity to distinguish damaged from undamaged tissue.

In anemia, where red blood cell count or hemoglobin concentration is low, oxygen delivery drops systemically rather than locally. The addressing mechanism blurs because mild hypoxia becomes a background condition rather than a site-specific signal, and the body can no longer distinguish the injury's address from the general noise. Iron deficiency compounds this problem at two levels simultaneously, because the same iron required for hemoglobin in red blood cells is also required for Tet3 to function as the enzyme that removes the epigenetic lock. A single mineral deficiency reduces oxygen delivery through anemia while also reducing the activity of the enzyme responsible for unlocking regeneration genes, which means the lock stays on and the signal that would direct its removal can't arrive with enough specificity to find the right door.

Aspirin is an unexpected confirmation that the medium matters as much as the message. Researchers directly compared the metabolic effects of aspirin with 48-hour fasting in mice and found convergent alterations in the plasma and heart metabolome (Pietrocola et al., 2020). Aspirin's active metabolite, salicylate, stimulates autophagy through the same caloric restriction pathway that fasting uses, and when administered to mice it caused a measurable surge in autophagy coincident with increased plasma salicylate concentration. The researchers explicitly state that salicylate recapitulates the mode of action of caloric restriction.

Aspirin operates on the signal delivery problem from three directions at once. It reduces blood viscosity by inhibiting platelet aggregation, which increases flow rate through narrowed or constricted channels and restores the velocity differentials that determine where immune cells attach and where nutrients exchange. It activates autophagy through the same AMPK pathway as fasting, which suppresses DNMT3a and lowers the global methylation pressure keeping regeneration genes locked. And it modulates histone methylation through COX-independent pathways, affecting the epigenetic landscape at a second level beyond DNA methylation by influencing how tightly chromatin is wound around the histones that package the genome.

In liver fibrosis, which is excessive collagen deposition maintained by the same suppressor-of-degrader mechanism that keloids use, aspirin attenuates fibrosis specifically through autophagy induction (2025). The compound that thins the blood also activates the cellular maintenance pathway that remodels disordered tissue, and it does both through a molecule derived from willow bark that humans have been using for thousands of years before anyone understood the mechanism.

The point is not that aspirin is a regeneration drug. The point is that the medium carrying the signal and the maintenance pathway receiving it are not independent systems. Improving the flow properties of the blood while simultaneously activating autophagy creates the conditions under which regeneration signals that were always being sent can finally arrive at concentration, at the right location, through channels that are open enough to carry them. The river has to be flowing for the message to reach the shore.

8. Abundance as Suppression

Paper 47 established that the body cannot maintain itself while it is still receiving. Paper 48 documented that the type of deficiency determines which organ axis activates. This paper has shown that the molecular lock on regeneration is maintained by an enzyme that is suppressed by autophagy, which activates only in withdrawal.

The uncomfortable implication is that abundance suppresses regeneration.

A body that never fasts maintains continuous mTOR activation, which keeps AMPK quiet, which prevents autophagy from activating, which leaves DNMT3a running unchecked, which keeps regeneration genes methylated. The lock stays on, not because something went wrong, but because the conditions for unlocking it never arrived.

In critically ill patients, continuous artificial feeding has been identified as a plausible cause of insufficient autophagy activation, even in the presence of other activating stressors like hypoxia and oxidative stress, because the feeding suppresses the very maintenance process the body needs most. The system that never lacks never sorts.

This reframes what populations living in scarcity may be experiencing at the molecular level. A body that fasts by necessity, not by choice or health protocol, runs autophagy cycles that periodically suppress DNMT3a. Regeneration genes that are permanently locked in a constantly-fed body may be periodically unlocking in a fasting one. The body in scarcity may have access to regenerative pathways that the body in abundance has epigenetically silenced.

A complete system maintains itself because maintenance is coded into it — the parts have to keep working, alone and together, or the whole fails. The environment changes around it, and the system performs regulation and stability because its existence depends on it.

The signal of lack may be the loudest signal in the genesis of repair. And the silence of abundance may be the quietest form of suppression the body knows.

References

FLUX Papers
- Paper 36 — Responsive. Signal vs. noise floor; lowering the noise floor allows genuine signal through.
- Paper 47 — Cellular Reconstruction. Autophagy; fasting; withdrawal as signal; "the signal of lack may be the loudest signal in the genesis of repair."
- Paper 48 — Division of Labor. Organ crosstalk axes; physics of routing; mutualistic vs parasitic division.

Scientific Literature — Epigenetic Locking & Müller Glia
- Reyes-Aguirre, L.I. & Lamas, M. (2016). "Oct4 Methylation-Mediated Silencing As an Epigenetic Barrier Preventing Müller Glia Dedifferentiation in a Murine Model of Retinal Injury." Frontiers in Neuroscience, 10:523.
- Jorstad, N.L. et al. (2017). "Stimulation of functional neuronal regeneration from Müller glia in adult mice." Nature, 548:103-107. ASCL1 + HDAC inhibitor enables adult mice to generate neurons from Müller glia.
- BioRxiv (2025). "Transient DNA methyltransferase 3a (DNMT3a) Inhibition Unlocks Dedifferentiation and Neurogenic Potential in Mouse Retinal Müller Glia." CRISPRi-mediated DNMT3a knockdown for 3-5 days reactivates ASCL1, Lin28, Nestin.
- PMC (2025). "Tet3-mediated DNA demethylation is essential for maintaining the dedifferentiation capacity of mammalian Müller glia." Tet3 regulated by metabolic factors including iron, vitamins A and C.

Scientific Literature — Natural DNMT Inhibitors
- PMC (2025). "A Systematic Review of Food-Derived DNA Methyltransferase Modulators." Polyphenols, flavonoids, isothiocyanates as natural DNMT inhibitors.
- Rajavelu, A. et al. (2011). "The inhibition of the mammalian DNA methyltransferase 3a (Dnmt3a) by dietary black tea and coffee polyphenols." BMC Biochemistry, 12:16. Theaflavins and chlorogenic acid inhibit DNMT3a at physiologically relevant concentrations.
- Pandey, M. et al. (2016). "Dietary Flavones as Dual Inhibitors of DNA Methyltransferases and Histone Methyltransferases." PLOS ONE. Apigenin, chrysin, luteolin as dual-action natural compounds.

Scientific Literature — Autophagy & DNMT3a
- PMC (2023). "RNautophagic regulation of DNMT3a-dependent DNA methylation." Starvation-activated autophagy remodels DNA methylation profile by inhibiting DNMT3a expression.

Scientific Literature — Fasting Timeline
- Longo, V. et al. USC Longevity Institute. 72-hour fast triggers stem cell regeneration and immune system reset.
- Fung, J. Stages of fasting: glycogen depletion, ketosis, autophagy, stem cell activation.

Scientific Literature — Photobiomodulation
- Begum, R. et al. (2013). "Treatment with 670 nm Light Up Regulates Cytochrome C Oxidase Expression and Reduces Inflammation in an Age-Related Macular Degeneration Model." PLOS ONE. 670nm as supplemented environmental light reduces retinal inflammation.
- PMC (2021). "670nm photobiomodulation modulates bioenergetics and oxidative stress, in rat Müller cells challenged with high glucose." 670nm reduces ROS and preserves mitochondrial integrity in Müller glia.

Scientific Literature — Scar Tissue & MMPs
- Imaizumi, R. et al. (2009). "Promoted activation of matrix metalloproteinase (MMP)-2 in keloid fibroblasts." Histopathology. MMP/TIMP imbalance in keloid formation.
- Ulrich, D. et al. (2010). "Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids." Journal of Plastic, Reconstructive & Aesthetic Surgery. TIMP overexpression as mechanism for pathological scarring; therapeutic implication to increase MMP activity.

Scientific Literature — Blood Medium & Aspirin
- Pietrocola, F. et al. (2020). "Autophagy-mediated metabolic effects of aspirin." Cell Death Discovery, 6:101. Aspirin vs. 48-hour fasting in mice; convergent alterations in the plasma and heart metabolome; autophagy induction.
- PMC (2025). "Aspirin Attenuates Liver Fibrosis via Autophagy Induction." Aspirin restores autophagic flux and reduces collagen deposition in liver fibrosis through autophagy pathway.
- PMC (2025). "Study Design and Rationale: Aspirin effects on Blood Viscosity and Microcirculation in Cardiovascular Patients." Blood viscosity as factor in disease progression; aspirin's effects on erythrocyte deformability and tissue oxygen delivery.
- Dove Medical Press (2025). "Repurposing Aspirin as a Potent Anti-Cancer Agent." Aspirin modulates histone methylation via KDM6A/B inhibition; enhances autophagy through LC3II/LC3I ratio increase and p62 reduction; mTOR pathway modulation.

ΑΩ ad infinitum ∞